Yahoo Suche Web Suche

  1. siemens.com wurde im letzten Monat von mehr als 10.000 Nutzern besucht

    Improve Lab Quality & Productivity, Create Transparency and Gain Energy Savings. Act Now. Siemens Offers Green Lab Solutions, Biocontainment, Regulatory Compliance and More.

Suchergebnisse

  1. Suchergebnisse:
  1. Spark Therapeutics is challenging the inevitability of genetic disease by discovering, developing and delivering treatments in ways unimaginable – until now.

  2. The company is currently developing several gene therapies to target a suite of diseases, including Haemophilia A and B, and several central nervous system diseases. In December 2019, the company was acquired by Hoffmann-La Roche for $4.3 billion. [6] [7] It now continues to operate as an independent subsidiary. [8]

  3. www.roche.com › innovation › structureSpark - Roche

    Spark Therapeutics was founded in 2013 and became a Member of the Roche Group in 2019. The organisation is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies for genetic diseases, including inherited retinal disorders, haemophilia, lysosomal storage disorders and neurodegenerative diseases.

  4. 12. Dez. 2022 · PHILADELPHIA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated gene therapy company today announced updated...

    • Spark Therapeutics, Inc.
  5. 23. Feb. 2022 · Spark Therapeutics is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies. Founded in 2013, Spark Therapeutics is the first company in the U.S. to receive FDA approval of a gene therapy for a genetic disease.

  6. Spark Therapeutics, Inc. | 87,207 followers on LinkedIn. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation. | At Spark® Therapeutics, we believe in...